Pfizer | PFE - Beneficio Bruto En Ventas

Precio De Mercado
26.75
Cambio Diario
0.49 1.87%
Mensual
-4.74%
Anual
11.78%
Q2 Expectativa
26.42




Beneficio Bruto En Ventas Cambio Fecha
AbbVie USD 12.54B 474M 2026-03
Abbott USD 5.86B 675M 2026-03
ALKERMES USD 338.34M 72.51M 2025-12
Amgen USD 6.89B 415M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
Bayer EUR 5.35B 1.02B 2025-09
Biogen USD 1.82B 169.5M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Coherus Biosciences USD 8.7M 853K 2025-12
Drreddys Laboratories INR 46.81B 10.24B 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
Glaxosmithkline GBP 8.75B 2.92B 2025-09
J&J USD 17.24B 642M 2026-03
Medtronic USD 5.41B 27M 2025-12
Merck USD 10.85B 2.57B 2025-12
Neurocrine Biosciences USD 787.9M 7M 2025-12
Novartis USD 10.25B 570M 2025-12
Novartis USD 10.82B 694M 2025-09
Pacira USD 142.25M 11.34M 2025-12
Perrigo USD 362.2M 14.9M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 157.37M 5.79M 2025-12
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Sanofi EUR 8.45B 3.02B 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12
Zoetis USD 1.64B 73M 2025-12